Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

× No keyword cloud information.

39 in total

Review 1. Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.

Authors: Ami A Shah; Livia Casciola-Rosen
Journal: Curr Opin Rheumatol Date: 2015-11 Impact factor: 5.006

2. Update on the treatment of granulomatosis with polyangiitis (Wegener's).

Authors: Carol A Langford
Journal: Curr Treat Options Cardiovasc Med Date: 2012-04

Review 3. Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.

Authors: Laura H Mariani; William F Pendergraft; Matthias Kretzler
Journal: Clin J Am Soc Nephrol Date: 2016-09-14 Impact factor: 8.237

Review 4. [Treatment strategies for ANCA-associated vasculitides].

Authors: B Hellmich
Journal: Z Rheumatol Date: 2015-06 Impact factor: 1.372

Review 5. Cancer and Scleroderma.

Authors: Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal: Rheum Dis Clin North Am Date: 2020-06-10 Impact factor: 2.670

Review 6. Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy.

Authors: Laura H Mariani; Matthias Kretzler
Journal: Nephrol Dial Transplant Date: 2015-06 Impact factor: 5.992

Review 7. Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide.

Authors: Deborah Robinson; Ginny Schulz; Rachel Langley; Kevin Donze; Kari Winchester; Cheryl Rodgers
Journal: J Pediatr Oncol Nurs Date: 2014-05-05 Impact factor: 1.636

Review 8. [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors: Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal: Z Rheumatol Date: 2017-11 Impact factor: 1.372

Review 9. Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs.

Authors: Christine Lebrun; Fanny Rocher
Journal: CNS Drugs Date: 2018-10 Impact factor: 5.749

Review 10. Characteristics and outcome of Goodpasture's disease in children.

Authors: Allan Bayat; Konstantinos Kamperis; Troels Herlin
Journal: Clin Rheumatol Date: 2012-08-26 Impact factor: 2.980